Anil Vachani

faculty photo
Associate Professor of Medicine at the Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center
Attending Physician, Philadelphia Veterans Administration Medical Center
Director of Clinical Research, Section of Interventional Pulmonology and Thoracic Oncology, Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine
Director of Bronchoscopy, Philadelphia VA Medical Center
Director, Lung Nodule Program, Perelman School of Medicine, Univeristy of Pennsylvania
Associate Director, Masters in Translational Research Program, ITMAT Educational Programs, Perelman School of Medicine, University of Pennsylvania
Co-Director Lung Cancer Screening Program, Perelman School of Medicine, University of Pennslvania
Department: Medicine

Contact information
Pulmonary, Allergy, and Critical Care Division
University of Pennsylvania Perelman School of Medicine
Suite 216, Stemmler Hall
3450 Hamilton Walk
Philadelphia, PA 19104
Office: 215.573.7931
Education:
B.S. (Genetics)
University of California, Berkeley, 1992.
B.A. (Economics)
University of California, Berkeley, 1992.
M.D. (Medicine)
University of California, San Francisco, 1996.
M.S. (Clinical Epidemiology)
University of Pennsylvania, Perelman School of Medicine, 2013.
Post-Graduate Training
Categorical Internal Medicine Residency Program, Hospital of the University of Pennsylvania, Department of Medicine , 1996-1999.
Fellowship, Pulmonary and Critical Care Medicine, Hospital of the University of Pennsylvania, Department of Medicine, 2000-2004.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Itmat Expertise

Dr. Vachani is interested in the molecular epidemiology of lung cancer and in discovery and validation of early detection biomarkers for thoracic malignancies. His research ranges from animal models to human translational studies and includes observational and correlative studies in early and late phase clinical trials.

Selected Publications

Vachani A, Lam S, Massion PP, Brown JK, Beggs M, Fish AL, Carbonell L, Wang SX, Mazzone PJ.: Development and Validation of a Risk Assessment Model for Pulmonary Nodules Using Plasma Proteins and Clinical Factors. Chest Page: Online ahead of print, Nov 2022 Notes: doi: 10.1016/j.chest.2022.10.038.

Vachani A, Zhou M, Ghosh S, Zhang S, Szapary P, Gaurav D, Kalsekar I.: Complications After Transthoracic Needle Biopsy of Pulmonary Nodules: A Population-Level Retrospective Cohort Analysis. J Am Coll Radiol 19(10): 1121-1129, Oct 2022 Notes: doi: 10.1016/j.jacr.2022.04.010.

Kim RY, Rendle KA, Mitra N, Saia CA, Neslund-Dudas C, Greenlee RT, Burnett-Hartman AN, Honda SA, Simoff MJ, Schapira MM, Croswell JM, Meza R, Ritzwoller DP, Vachani A.: Socioeconomic Status as a Mediator of Racial Disparity in Annual Lung Cancer Screening Adherence. Am J Respir Crit Care Med Oct 2022 Notes: doi: 10.1164/rccm.202208-1590LE.

Kim RY, Rendle KA, Mitra N, Saia CA, Neslund-Dudas C, Greenlee RT, Burnett-Hartman AN, Honda SA, Simoff MJ, Schapira MM, Croswell JM, Meza R, Ritzwoller DP, Vachani A: Racial Disparities in Adherence to Annual Lung Cancer Screening and Recommended Follow-up Care: A Multicenter Cohort Study. Ann Am Thorac Soc 19(9): 1561-1569, Sep 2022 Notes: doi: 10.1513/AnnalsATS.202111-1253OC.

Ma L, Sun D, Xiu G, Lazarus P, Vachani A, Penning TM, Whitehead AS, Muscat JE.: Quantification of Plasma 8-Isoprostane by High-Performance Liquid Chromatography with Tandem Mass Spectrometry in a Case-Control Study of Lung Cancer. Int J Environ Res Public Health 19(19): 12488, Sep 2022 Notes: doi: 10.3390/ijerph191912488.

DiBardino DM, Kim RY, Cao Y, Andronov M, Lanfranco AR, Haas AR, Vachani A, Ma KC, Hutchinson CT.: Diagnostic Yield of Cone-beam-Derived Augmented Fluoroscopy and Ultrathin Bronchoscopy Versus Conventional Navigational Bronchoscopy Techniques. J Bronchology Interv Pulmonol Page: Online ahead of print, Aug 2022 Notes: doi: 10.1097/LBR.0000000000000883.

Vachani A, Carroll NM, Simoff MJ, Neslund-Dudas C, Honda S, Greenlee RT, Rendle KA, Burnett-Hartman A, Ritzwoller DP.: Stage Migration and Lung Cancer Incidence After Initiation of Low-Dose CT Screening. J Thorac Oncol Page: S1556-0864(22)01553-2, Aug 2022 Notes: doi: 10.1016/j.jtho.2022.08.011.

Chubak J, Burnett-Hartman AN, Barlow WE, Corley DA, Croswell JM, Neslund-Dudas C, Vachani A, Silver MI, Tiro JA, Kamineni A.: Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment Interval. Cancer Epidemiol Biomarkers Prev 31(8): 1517-1520, Aug 2022 Notes: doi: 10.1158/1055-9965.EPI-22-0232.

Kennedy GT, Mitra N, Penning TM, Whitehead AS, Vachani A.: Peripheral blood leukocyte mitochondrial DNA content and risk of lung cancer. Transl Lung Cancer Res 11(7): 1268-1278, Jul 2022 Notes: doi: 10.21037/tlcr-21-979.

Akulian JA, Molena D, Wahidi MM, Chen A, Yu D, Maldonado F, Lee H, Vachani A, Yarmus L; Interventional Pulmonary Outcomes Group (IPOG).: A Direct Comparative Study of Bronchoscopic Navigation Planning Platforms for Peripheral Lung Navigation: The ATLAS Study. J Bronchology Interv Pulmonol 29(3): 171-178, Jul 2022 Notes: doi: 10.1097/LBR.0000000000000806.

back to top
Last updated: 12/07/2022
The Trustees of the University of Pennsylvania